[HTML][HTML] Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity–Exploring the armoury of obscurity

K Singh, M Bhori, YA Kasu, G Bhat, T Marar - Saudi Pharmaceutical Journal, 2018 - Elsevier
Cancer is the leading cause of mortality worldwide, accounting for almost 13% of deaths in
the world. Among the conventional cancer treatments, chemotherapy is most frequently …

Melatonin and its ubiquitous anticancer effects

S Bhattacharya, KK Patel, D Dehari, AK Agrawal… - Molecular and cellular …, 2019 - Springer
Abstract Melatonin (N-acetyl-5-methoxy-tryptamine), which is generally considered as
pleiotropic and multitasking molecule, secretes from pineal gland at night under normal light …

Cancer anorexia‐cachexia syndrome: current issues in research and management

A Inui - CA: a cancer journal for clinicians, 2002 - Wiley Online Library
Cachexia is among the most debilitating and life‐threatening aspects of cancer. Associated
with anorexia, fat and muscle tissue wasting, psychological distress, and a lower quality of …

Cancer cachexia: mechanisms and clinical implications

CL Donohoe, AM Ryan… - … research and practice, 2011 - Wiley Online Library
Cachexia is a multifactorial process of skeletal muscle and adipose tissue atrophy resulting
in progressive weight loss. It is associated with poor quality of life, poor physical function …

Melatonin: reducing the toxicity and increasing the efficacy of drugs

RJ Reiter, D Tan, RM Sainz, JC Mayo… - Journal of Pharmacy …, 2002 - Wiley Online Library
Abstract Melatonin (N‐acetyl‐5‐methoxytryptamine) is a molecule with a very wide
phylogenetic distribution from plants to man. In vertebrates, melatonin was initially thought to …

Role and therapeutic potential of melatonin in various type of cancers

S Gurunathan, M Qasim, MH Kang… - OncoTargets and …, 2021 - Taylor & Francis
Cancer is a large group of diseases and the second leading cause of death worldwide.
Lung, prostate, colorectal, stomach, and liver cancers are the most common types of cancer …

Clinical uses of melatonin: evaluation of human trials

EJ Sánchez-Barceló, MD Mediavilla… - Current medicinal …, 2010 - ingentaconnect.com
During the last 20 years, numerous clinical trials have examined the therapeutic usefulness
of melatonin in different fields of medicine. The objective of this article is to review, in depth …

Melatonin: from basic research to cancer treatment clinics

Vijayalaxmi, CR Thomas Jr, RJ Reiter… - Journal of Clinical …, 2002 - ascopubs.org
Melatonin, the chief secretory product of the pineal gland, is a direct free radical scavenger,
an indirect antioxidant, as well as an important immunomodulatory agent. In both in vitro and …

Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy

XM Wang, TJ Lehky, JM Brell, SG Dorsey - Cytokine, 2012 - Elsevier
Chemotherapy-induced peripheral neuropathy (CIPN), a dose-limiting neurotoxic effect of
chemotherapy, is the most common reason for early cessation of cancer treatment. This can …

Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status

P Lissoni, S Barni, M Mandala, A Ardizzoia… - European Journal of …, 1999 - Elsevier
Melatonin (MLT) has been proven to counteract chemotherapy toxicity, by acting as an anti-
oxidant agent, and to promote apoptosis of cancer cells, so enhancing chemotherapy …